What Are the Stages of Cancer? Stage I, II, III and IV Explained
Cancer stage describes how much cancer is present and how far it has spread at diagnosis. Many cancers use stages 0 to IV, but staging systems differ by cancer type.
Short answer
Lower stages generally describe more localized disease, while stage IV often indicates distant spread in solid tumors. Stage 0 is used in some cancers for noninvasive in-situ disease, but these rules are not universal and stage alone cannot predict one person’s outcome.
What does stage 0 mean?
In cancers that use this category, stage 0 usually describes abnormal or in-situ cells that have not invaded neighboring tissue. Not every cancer uses stage 0.
What do stages I, II and III mean?
They usually represent increasing combinations of tumor size, local extension or nearby lymph-node involvement, but details differ substantially by cancer type.
What does stage IV mean?
In many solid tumors it indicates distant spread. It is not a universal definition for all cancers and does not mean every case follows the same course.
What is TNM?
T generally describes the primary tumor, N regional lymph nodes and M distant metastasis. Cancer-specific rules combine these into an overall stage.
What does the evidence say together?
Across many cancers, earlier stage at diagnosis is generally associated with better outcomes, but stage is not a substitute for cancer type, biology or treatment, and staging systems are not identical across cancers.
How should I use this information?
Stage alone is not enough to estimate an individual prognosis or choose treatment.
What are the key studies?
Original sources: Each study below links to its original record with a descriptive title.
Study 1: Early cancer diagnosis outcomes systematic review
- What did it study?
- A systematic review synthesized studies relating earlier cancer diagnosis or stage at diagnosis to survival and other clinical outcomes.
- What did it find?
- Earlier diagnosis was generally associated with better survival and other outcomes across many included studies.
- What are its limits?
- Cancer types, study designs and health systems differ, so no single effect estimate applies to everyone.
- What can we take from it?
- The evidence supports the importance of stage while showing that it is not an individual prognosis or a substitute for cancer type and biology.
Study 2: Cancer stage compared with mortality in randomized screening trials
- What did it study?
- An analysis of randomized screening trials compared changes in late-stage cancer incidence with changes in mortality to test stage as a surrogate outcome.
- What did it find?
- Reductions in late-stage cancer did not always perfectly correspond to mortality reductions.
- What are its limits?
- Cancers, screening methods and follow-up differ, and false results or overdiagnosis can occur; detecting more cases alone does not prove benefit.
- What can we take from it?
- The evidence supports the importance of stage while showing that it is not an individual prognosis or a substitute for cancer type and biology.
Study 3: Reporting stage at diagnosis: opportunities for improvement
- What did it study?
- A study examined the quality and completeness of stage-at-diagnosis reporting and opportunities to improve its use in care and surveillance.
- What did it find?
- High-quality stage data are important for care, surveillance and cancer-control evaluation.
- What are its limits?
- Cancer types, study designs and health systems differ, so no single effect estimate applies to everyone.
- What can we take from it?
- The evidence supports the importance of stage while showing that it is not an individual prognosis or a substitute for cancer type and biology.
Core sources
Stage alone is not enough to estimate an individual prognosis or choose treatment.
Editorial review
The Reffaq Cancer Magazine team prepared this page using official health sources and original studies appropriate to the question. The source-review date appears on the page, and when a qualified medical professional reviews the content we identify the reviewer and their role clearly.